Zlatev, Ivan http://orcid.org/0000-0003-2797-3032
Castoreno, Adam
Brown, Christopher R
Qin, June
Waldron, Scott
Schlegel, Mark K http://orcid.org/0000-0002-0127-608X
Degaonkar, Rohan
Shulga-Morskaya, Svetlana
Xu, Huilei
Gupta, Swati http://orcid.org/0000-0002-0312-2834
Matsuda, Shigeo
Akinc, Akin
Rajeev, Kallanthottathil G
Manoharan, Muthiah
Maier, Martin A
Jadhav, Vasant
Article History
Received: 2 June 2017
Accepted: 12 March 2018
First Online: 14 May 2018
Competing interests
: All authors are or were employees of Alnylam Pharmaceuticals when they contributed to this work. REVERSIR is a trademark of Alnylam Pharmaceuticals.